Allan Kengo

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Allan Kengo, Kamunkhwala Gausi, Ruth Nabisere, Joseph Musaazi, Allan Buzibye, Denis Omali, Rob Aarnoutse, Mohammed Lamorde, Kelly E Dooley, Derek James Sloan, Christine Sekaggya-Wiltshire, Paolo Denti
Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin. Antimicrobial agents and chemotherapy (2023)
Allan Kengo, Ruth Nabisere, Kamunkhwala Gausi, Joseph Musaazi, Allan Buzibye, Denis Omali, Rob Aarnoutse, Mohammed Lamorde, Kelly E Dooley, Derek James Sloan, Paolo Denti, Christine Sekaggya-Wiltshire
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin. Antimicrobial agents and chemotherapy (2023)

Allan Kengo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Allan Kengo